Jayesh Vora

436 total citations
10 papers, 263 citations indexed

About

Jayesh Vora is a scholar working on Molecular Biology, Organic Chemistry and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Jayesh Vora has authored 10 papers receiving a total of 263 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Organic Chemistry and 2 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Jayesh Vora's work include Chemical Synthesis and Analysis (2 papers), Chemotherapy-induced cardiotoxicity and mitigation (2 papers) and Quinazolinone synthesis and applications (2 papers). Jayesh Vora is often cited by papers focused on Chemical Synthesis and Analysis (2 papers), Chemotherapy-induced cardiotoxicity and mitigation (2 papers) and Quinazolinone synthesis and applications (2 papers). Jayesh Vora collaborates with scholars based in United States. Jayesh Vora's co-authors include Carla Heise, Mehdi Boroujerdi, Evelyn N. Garrett, Alex L. Harris, Sharon L. Aukerman, Emil Samara, Sang Hoon Lee, Daniel L. Menezes, Helen Ye and Arnold B. Gelb and has published in prestigious journals such as Clinical Cancer Research, Journal of Controlled Release and Journal of Pharmacy and Pharmacology.

In The Last Decade

Jayesh Vora

10 papers receiving 253 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jayesh Vora United States 7 146 57 45 43 36 10 263
Kenneth Francis Hofland Denmark 12 131 0.9× 114 2.0× 54 1.2× 21 0.5× 69 1.9× 16 330
Keith Moser Austria 10 121 0.8× 133 2.3× 42 0.9× 26 0.6× 53 1.5× 80 358
Andrea Clarke United States 8 166 1.1× 73 1.3× 56 1.2× 16 0.4× 80 2.2× 17 368
Matthew White United States 9 154 1.1× 53 0.9× 33 0.7× 17 0.4× 26 0.7× 13 343
Bertrand Heckmann Belgium 11 250 1.7× 103 1.8× 70 1.6× 87 2.0× 45 1.3× 19 425
Patrizia Banfi Italy 10 176 1.2× 63 1.1× 50 1.1× 38 0.9× 20 0.6× 18 225
Ludovica Taglieri Italy 11 101 0.7× 178 3.1× 58 1.3× 40 0.9× 47 1.3× 18 345
J Edmonson United States 3 48 0.3× 90 1.6× 66 1.5× 15 0.3× 25 0.7× 7 209
Masato Komoda Japan 11 183 1.3× 186 3.3× 91 2.0× 58 1.3× 54 1.5× 32 408
Daniel Kukral United States 8 105 0.7× 68 1.2× 28 0.6× 61 1.4× 28 0.8× 9 265

Countries citing papers authored by Jayesh Vora

Since Specialization
Citations

This map shows the geographic impact of Jayesh Vora's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jayesh Vora with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jayesh Vora more than expected).

Fields of papers citing papers by Jayesh Vora

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jayesh Vora. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jayesh Vora. The network helps show where Jayesh Vora may publish in the future.

Co-authorship network of co-authors of Jayesh Vora

This figure shows the co-authorship network connecting the top 25 collaborators of Jayesh Vora. A scholar is included among the top collaborators of Jayesh Vora based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jayesh Vora. Jayesh Vora is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Byrne, Barry J., Bruce A. Barshop, Richard J. Barohn, et al.. (2012). POM-001 Phase 1/2 Study of BMN 701, GILT-tagged Recombinant Human (rh) GAA in Late-Onset Pompe Disease: Preliminary Report. Molecular Genetics and Metabolism. 105(2). S24–S24. 2 indexed citations
2.
McBride, Christopher M., Paul A. Renhowe, Carla Heise, et al.. (2006). Design and structure–activity relationship of 3-benzimidazol-2-yl-1H-indazoles as inhibitors of receptor tyrosine kinases. Bioorganic & Medicinal Chemistry Letters. 16(13). 3595–3599. 40 indexed citations
3.
Frazier, Kelly, Christopher M. McBride, Sabina Pecchi, et al.. (2006). Design and structure–activity relationship of heterocyclic analogs of 4-amino-3-benzimidazol-2-ylhydroquinolin-2-ones as inhibitors of receptor tyrosine kinases. Bioorganic & Medicinal Chemistry Letters. 16(8). 2247–2251. 11 indexed citations
4.
Lee, Sang Hoon, Daniel L. Menezes, Jayesh Vora, et al.. (2005). In vivo Target Modulation and Biological Activity of CHIR-258, a Multitargeted Growth Factor Receptor Kinase Inhibitor, in Colon Cancer Models. Clinical Cancer Research. 11(10). 3633–3641. 148 indexed citations
5.
Vora, Jayesh, et al.. (1999). Influence of dosing vehicles on the preclinical pharmacokinetics of phenolic antioxidants.. PubMed. 104(1). 93–106. 5 indexed citations
6.
Vora, Jayesh, Ban‐An Khaw, Jagat Narula, & Mehdi Boroujerdi. (1996). Protective Effect of Butylated Hydroxyanisole on Adriamycin-induced Cardiotoxicity. Journal of Pharmacy and Pharmacology. 48(9). 940–944. 26 indexed citations
7.
Vora, Jayesh & Mehdi Boroujerdi. (1996). Pharmacokinetic-toxicodynamic Relationships of Adriamycin in Rat: Prediction of Butylated Hydroxyanisole-mediated Reduction in Anthracycline Cardiotoxicity. Journal of Pharmacy and Pharmacology. 48(12). 1264–1269. 9 indexed citations
8.
Vora, Jayesh & Mehdi Boroujerdi. (1995). Enhanced Aqueous Solubility of Phenolic Antioxidants Using Modified β-Cyclodextrins. Drug Development and Industrial Pharmacy. 21(4). 495–502. 5 indexed citations
9.
Vora, Jayesh, et al.. (1993). Investigation of the Relative Affinity of Doxorubicin for Neutral and Negatively Charged Particulate Carriers. Drug Development and Industrial Pharmacy. 19(7). 759–771. 9 indexed citations
10.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kenneth Francis Hofland Breakdown of academic impact, for papers by Keith Moser Breakdown of academic impact, for papers by Andrea Clarke Breakdown of academic impact, for papers by Matthew White Breakdown of academic impact, for papers by Bertrand Heckmann Breakdown of academic impact, for papers by Patrizia Banfi Breakdown of academic impact, for papers by Ludovica Taglieri Breakdown of academic impact, for papers by J Edmonson Breakdown of academic impact, for papers by Masato Komoda Breakdown of academic impact, for papers by Daniel Kukral
Rankless by CCL
2026